Nov 2018
Tasmania remains the only state in Australia unable to use an online application system that helps streamline access to medicinal cannabis. Unnecessary hurdles are also said to be experienced with people needing to see their GP first to obtain a referral to a relevant specialist. Experts claim that this process creates an unnecessary burden on health system and extends the waiting time for patients. Read the article here.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
What’s most important in business – purpose or profit? At ANTG we get to achieve both.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >